MMRF
CME icon

Michelson Medical Research Foundation’s CME Group CME Stock Holding History

Michelson Medical Research Foundation’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.61M Buy
+39,000
New +$10.8M 7.96% 4

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Michelson Medical Research Foundation's CME Position: Q2 2026 in Review

Michelson Medical Research Foundation opened a new position in CME Group (CME) in Q2 2026: 39,000 shares worth $8.61M. The stake represents 7.96% of the portfolio and ranks #4 among its holdings.

1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Michelson Medical Research Foundation held 39,000 shares of CME Group worth $8.61M as of Q2 2026.
  • CME Group was a new Michelson Medical Research Foundation position in Q2 2026.
  • CME Group made up 7.96% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #4 holding.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.